{"id":"https://openalex.org/W2006144672","doi":"https://doi.org/10.1111/j.1600-0404.1990.tb00949.x","title":"Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system","display_name":"Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-29","ids":{"openalex":"https://openalex.org/W2006144672","doi":"https://doi.org/10.1111/j.1600-0404.1990.tb00949.x","mag":"2006144672","pmid":"https://pubmed.ncbi.nlm.nih.gov/2327233"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0404.1990.tb00949.x","doi":"https://doi.org/10.1111/j.1600-0404.1990.tb00949.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1990.tb00949.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006144672"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030570842","display_name":"H\u00e5kan Askmark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"H\u00e5kan Askmark","raw_affiliation_strings":["Department of Neurology, Uppsala University Hospital, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Uppsala University Hospital, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110266205","display_name":"Bengt\u2010Erik Wiholm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296697866","display_name":"National Board of Health and Welfare","ror":"https://ror.org/01v4pc162","country_code":"SE","type":"government","lineage":["https://openalex.org/I1296697866"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bengt-Erik Wiholm","raw_affiliation_strings":["Department of Drugs, National Board of Health and Welfare, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drugs, National Board of Health and Welfare, Uppsala, Sweden","institution_ids":["https://openalex.org/I1296697866"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5030570842"],"corresponding_institution_ids":["https://openalex.org/I1342360035"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":null,"fwci":1.9433,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.81807174,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"81","issue":"2","first_page":"131","last_page":"140"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0934000015258789,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.015599999576807022,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.996999979019165},{"id":"https://openalex.org/keywords/spontaneous-reporting","display_name":"spontaneous reporting","score":0.8190000057220459},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.621999979019165},{"id":"https://openalex.org/keywords/skin-reactions","display_name":"skin reactions","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.7730000019073486},{"id":"https://openalex.org/keywords/hematological-adverse-events","display_name":"hematologic adverse events","score":0.824999988079071},{"id":"https://openalex.org/keywords/pancytopenia","display_name":"pancytopenia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/agranulocytosis","display_name":"agranulocytosis","score":1.0},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.824999988079071},{"id":"https://openalex.org/keywords/alcohol-abuse","display_name":"alcohol abuse","score":0.8709999918937683},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.4699999988079071},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C113775271","wikidata":"https://www.wikidata.org/wiki/Q3709969","display_name":"Dyscrasia","level":4,"score":0.886512041091919},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.8772048354148865},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6811299324035645},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6606482267379761},{"id":"https://openalex.org/C2779382419","wikidata":"https://www.wikidata.org/wiki/Q1757427","display_name":"Pancytopenia","level":3,"score":0.5899291038513184},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.5827623605728149},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4885447919368744},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4781416654586792},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3637082576751709},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.1915622353553772},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.18061602115631104},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.09558629989624023},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C2776396001","wikidata":"https://www.wikidata.org/wiki/Q250694","display_name":"Plasma cell","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006402","descriptor_name":"Hematologic Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006402","descriptor_name":"Hematologic Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0404.1990.tb00949.x","doi":"https://doi.org/10.1111/j.1600-0404.1990.tb00949.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1990.tb00949.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},{"id":"pmid:2327233","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2327233","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Scandinavica","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W15191073","https://openalex.org/W1488839803","https://openalex.org/W1538284670","https://openalex.org/W1558470276","https://openalex.org/W1992827109","https://openalex.org/W1999489131","https://openalex.org/W2007764686","https://openalex.org/W2032057937","https://openalex.org/W2042737092","https://openalex.org/W2054460525","https://openalex.org/W2067115320","https://openalex.org/W2070110142","https://openalex.org/W2070459725","https://openalex.org/W2073365198","https://openalex.org/W2102554720","https://openalex.org/W2121093738","https://openalex.org/W2136143199","https://openalex.org/W2412170813","https://openalex.org/W2413601247","https://openalex.org/W2481005860"],"related_works":["https://openalex.org/W2375408576","https://openalex.org/W2049507887","https://openalex.org/W3145510988","https://openalex.org/W2171033955","https://openalex.org/W4379779454","https://openalex.org/W2768450320","https://openalex.org/W2410092844","https://openalex.org/W7118883799","https://openalex.org/W4237086758","https://openalex.org/W1535115254"],"abstract_inverted_index":{"A":[0],"survey":[1],"was":[2,49],"made":[3],"of":[4,43,99,109,113,118,138,149],"505":[5],"reports":[6,33,74],"on":[7,75],"713":[8],"adverse":[9,45],"reactions":[10,46,71],"to":[11,14,47,58,136,144,160],"carbamazepine":[12,48],"submitted":[13],"the":[15,25,29,32,96,100,105,114],"Swedish":[16],"Adverse":[17],"Drug":[18],"Reactions":[19],"Advisory":[20],"Committee":[21],"from":[22],"1965-1987.":[23],"For":[24],"period":[26],"after":[27],"1972,":[28],"relation":[30],"between":[31],"and":[34,78,89,128,153,156],"sales":[35],"statistics":[36],"could":[37],"be":[38,137,145],"investigated.":[39],"The":[40,141],"total":[41],"incidence":[42,117],"reported":[44,68,119],"4.5":[50],"per":[51,60],"million":[52,61],"defined":[53],"daily":[54,63],"doses":[55,64],"(DDD),":[56],"corresponding":[57],"2.7":[59],"prescribed":[62],"(PDD).":[65],"Most":[66],"often":[67],"were":[69,82],"skin":[70,91,168],"(48%),":[72],"but":[73],"haematological":[76,101,133],"(12%)":[77],"hepatic":[79,87],"disorders":[80,88],"(10%)":[81],"also":[83],"frequent.":[84],"Virtually":[85],"all":[86],"severe":[90],"reactions,":[92,102,155],"as":[93,95,124],"well":[94],"majority":[97],"(60%)":[98],"occurred":[103],"within":[104],"first":[106],"2":[107],"months":[108],"treatment.":[110],"In":[111],"view":[112],"very":[115],"low":[116],"serious":[120,167],"blood":[121,151],"dyscrasias,":[122],"such":[123],"pancytopenia":[125],"(0.04/million":[126],"PDD)":[127],"agranulocytosis":[129],"(0.06/million":[130],"PDD),":[131],"continuous":[132],"monitoring":[134],"seems":[135],"little":[139],"value.":[140],"elderly":[142],"appear":[143],"at":[146],"increased":[147],"risk":[148],"developing":[150,166],"dyscrasias":[152],"liver":[154],"alcohol":[157],"abusers":[158],"seem":[159],"represent":[161],"a":[162],"high-risk":[163],"group":[164],"for":[165],"reactions.":[169]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006144672","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
